Fierce Pharma26 分钟
AstraZeneca offers early look at Datroway-Tagrisso combo in EGFR lung cancer as phase 3 ...
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...